{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:30:39Z","timestamp":1790101839914,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.yebeh.2007.02.014","type":"journal-article","created":{"date-parts":[[2007,4,7]],"date-time":"2007-04-07T11:17:16Z","timestamp":1175944636000},"page":"515-520","source":"Crossref","is-referenced-by-count":16,"title":["Psychosis: Atypical limbic epilepsy versus limbic hyperexcitability with onset at puberty?"],"prefix":"10.1016","volume":"10","author":[{"given":"Frank R.","family":"Sharp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Hendren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2007.02.014_bib1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia [see comments]","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.yebeh.2007.02.014_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-2007-979354","article-title":"The NMDA antagonist model for schizophrenia: promise and pitfalls","volume":"31","author":"Abi-Saab","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.yebeh.2007.02.014_bib3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/ajp.154.6.805","article-title":"Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers","volume":"154","author":"Breier","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.yebeh.2007.02.014_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.yebeh.2007.02.014_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/hrp.7.3.125","article-title":"NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders","volume":"7","author":"Krystal","year":"1999","journal-title":"Harv Rev Psychiatry"},{"key":"10.1016\/j.yebeh.2007.02.014_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0893-133X(95)00137-3","article-title":"NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers","volume":"14","author":"Malhotra","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.yebeh.2007.02.014_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0893-133X(99)00118-9","article-title":"The effects of a sub-anaesthetic dose of ketamine on human selective attention","volume":"22","author":"Oranje","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.yebeh.2007.02.014_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-3956(99)00031-X","article-title":"Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans","volume":"34","author":"Vollenweider","year":"2000","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.yebeh.2007.02.014_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00002018-199513050-00002","article-title":"Neurological and psychiatric adverse effects of anaesthetics: epidemiology and treatment","volume":"13","author":"Klafta","year":"1995","journal-title":"Drug Saf"},{"key":"10.1016\/j.yebeh.2007.02.014_bib10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00001756-199504190-00011","article-title":"Ketamine activates psychosis and alters limbic blood flow in schizophrenia","volume":"6","author":"Lahti","year":"1995","journal-title":"NeuroReport"},{"key":"10.1016\/j.yebeh.2007.02.014_bib11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/cne.902200404","article-title":"Altered metabolic activity in the cerebral cortex of rats exposed to ketamine","volume":"220","author":"Hammer","year":"1983","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.yebeh.2007.02.014_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1192\/S0007125000293598","article-title":"Glutamatergic aspects of schizophrenia","author":"Tamminga","year":"1999","journal-title":"Br J Psychiatry Suppl"},{"key":"10.1016\/j.yebeh.2007.02.014_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0924-977X(96)00039-9","article-title":"Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)","volume":"7","author":"Vollenweider","year":"1997","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.yebeh.2007.02.014_bib14","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1124\/jpet.102.048140","article-title":"Chronic administration of haloperidol and olanzapine attenuates ketamine-induced brain metabolic activation","volume":"305","author":"Duncan","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.yebeh.2007.02.014_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.yebeh.2005.04.012","article-title":"Psychiatric comorbidity in epilepsy","volume":"7","author":"Swinkels","year":"2005","journal-title":"Epilepsy Behav"},{"issue":"Suppl. 4","key":"10.1016\/j.yebeh.2007.02.014_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1528-1167.2005.463009.x","article-title":"Depression and mania in patients with epilepsy","volume":"46","author":"Schmitz","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2007.02.014_bib17","first-page":"14","article-title":"Guidelines for recognition and treatment of the psychoses associated with epilepsy","volume":"105","author":"Tugendhaft","year":"2005","journal-title":"Acta Neurol Belg"},{"issue":"Suppl. 2","key":"10.1016\/j.yebeh.2007.02.014_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.0013-9580.2004.452004.x","article-title":"Recognition of the various expressions of anxiety, psychosis, and aggression in epilepsy","volume":"45","author":"Kanner","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2007.02.014_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/ebeh.2000.0090","article-title":"Psychosis of epilepsy: a neurologist\u2019s perspective","volume":"1","author":"Kanner","year":"2000","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2007.02.014_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1615\/CritRevNeurobiol.v12.i1-2.20","article-title":"Schizophrenia and glutamatergic transmission","volume":"12","author":"Tamminga","year":"1998","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.yebeh.2007.02.014_bib21","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0006-3223(95)00046-1","article-title":"Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia?","volume":"38","author":"Farber","year":"1995","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2007.02.014_bib22","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1126\/science.1835799","article-title":"NMDA antagonist neurotoxicity: mechanism and prevention","volume":"254","author":"Olney","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.yebeh.2007.02.014_bib23","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1046\/j.1460-9568.2000.00018.x","article-title":"Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK-801) injures pyramidal neurons in rat retrosplenial cortex","volume":"12","author":"Tomitaka","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.yebeh.2007.02.014_bib24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0166-2236(00)01817-8","article-title":"Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?","volume":"24","author":"Sharp","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.yebeh.2007.02.014_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0304-3940(95)11864-S","article-title":"Intraperitoneal dizocilpine induces cortical spike\u2013wave seizure discharges in rats","volume":"196","author":"Feinberg","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.yebeh.2007.02.014_bib26","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2174\/0929867013372328","article-title":"The NMDA receptor complex: a promising target for novel antiepileptic strategies","volume":"8","author":"Kohl","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.yebeh.2007.02.014_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/med.20084","article-title":"Competitive AMPA receptor antagonists","volume":"27","author":"Catarzi","year":"2007","journal-title":"Med Res Rev"},{"key":"10.1016\/j.yebeh.2007.02.014_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pneurobio.2003.11.003","article-title":"Emergent properties of CNS neuronal networks as targets for pharmacology: application to anticonvulsant drug action","volume":"72","author":"Faingold","year":"2004","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.yebeh.2007.02.014_bib29","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1126\/science.2660263","article-title":"Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs [see comments]","volume":"244","author":"Olney","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.yebeh.2007.02.014_bib30","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ana.410300609","article-title":"MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex","volume":"30","author":"Sharp","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2007.02.014_bib31","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/0306-4522(94)90345-X","article-title":"Phencyclidine induction of the hsp 70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels","volume":"62","author":"Sharp","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.yebeh.2007.02.014_bib32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/exnr.1996.0022","article-title":"Haloperidol prevents ketamine- and phencyclidine-induced HSP70 protein expression but not microglial activation","volume":"137","author":"Nakki","year":"1996","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2007.02.014_bib33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/01.STR.27.4.743","article-title":"Effect of age and sex on N-methyl-d-aspartate antagonist-induced neuronal necrosis in rats","volume":"27","author":"Auer","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.yebeh.2007.02.014_bib34","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/sj.npp.1300878","article-title":"Atypical antipsychotics and a Src kinase inhibitor (PP1) prevent cortical injury produced by the psychomimetic, noncompetitive NMDA receptor antagonist MK-801","volume":"31","author":"Dickerson","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.yebeh.2007.02.014_bib35","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.neuropharm.2004.08.018","article-title":"The mGlu2\/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801: possible implications for psychosis","volume":"47","author":"Carter","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yebeh.2007.02.014_bib36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jnr.490330413","article-title":"Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine","volume":"33","author":"Sharp","year":"1992","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.yebeh.2007.02.014_bib37","first-page":"555","article-title":"Neuronal injury produced by NMDA antagonists can be detected using heat shock proteins and can be blocked with antipsychotics","volume":"30","author":"Sharp","year":"1994","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.yebeh.2007.02.014_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0920-9964(96)00024-2","article-title":"Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity","volume":"21","author":"Farber","year":"1996","journal-title":"Schizophr Res"},{"issue":"Suppl. B","key":"10.1016\/j.yebeh.2007.02.014_bib39","first-page":"43","article-title":"Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity","volume":"55","author":"Olney","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.yebeh.2007.02.014_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.mp.4000912","article-title":"Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity","volume":"7","author":"Farber","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.yebeh.2007.02.014_bib41","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.4088\/JCP.v67n0703","article-title":"A 7-week, randomized, double-blind trial of olanzapine\/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression","volume":"67","author":"Brown","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.yebeh.2007.02.014_bib42","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/j.1440-1614.2006.01815.x","article-title":"Anticonvulsants in bipolar disorder","volume":"40","author":"Bowden","year":"2006","journal-title":"Aust NZ J Psychiatry"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550500700042X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550500700042X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T06:01:15Z","timestamp":1556344875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550500700042X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S152550500700042X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2007.02.014","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}